Matches in SemOpenAlex for { <https://semopenalex.org/work/W821444018> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W821444018 endingPage "141" @default.
- W821444018 startingPage "136" @default.
- W821444018 abstract "Objective: To evaluate the dynamic change of Th1/Th2 cytokines in serum, peritoneal lavage fluid (PLF) and splenic macrophages (SM) in rats with severe peritonitis, and to observe the therapeutic preparation. Methods: Severe peritonitis (SP) model was induced by intraperitoneal injection of E. coli and B. frag, and mild peritonitis (MP) model was induced by cecal ligation and punching. Then the following experiments were done: (1) Survival rates of animals after every 6 hrs in the 72 hrs after modeling were recorded, serum and PLF levels of cytokines, including tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ),and interleukin-10 (IL-10), 6 hrs, 12 hrs, 24 hrs and 48 hrs after modeling were measured. (2) Model rats were treated with rlL-12 or SMI, the survival rate was recorded and serum levels of TNF-α, INF-γ, and IL-10before and after treatment were measured, and (3) amount of these cytokines produced by SM were determined 6 hrs, 12 hrs and 24 hrs after treatment. The survival rates and levels of cytokines were then compared between the groups (model group treated with rlL-12 or SMI, untreated model group, and blank group). Results: Serum and PLF levels of IFN-γ, TNF-α at all the time points in SP rats were significantly lower than those in MP rats while those of IL-10 6 hrs and 12 hrs after modeling were significantly higher in the former than that in the latter ( P＜0.05). IFN-γ secretion of SM in SP rats was significantly higher than that in MP rats 6 hrs after modeling (P＜0.05). Administration of rlL-12 or SMI given before modeling could improve the survival rate of the model rats (P＜0.05) and cause significant increase of the serum level and SM secretion of IFN-γ. Conclusion: Imbalance in promoting/antagonizing inflammatory cytokines and Th2 response dominance appear in SP rats early at the initiating stage, and SM secretion of inflammation promoting factor also reduces. Administration in time of rlL-12 and SMI, may increase the survival rate, and its mechanism may be related with their i" @default.
- W821444018 created "2016-06-24" @default.
- W821444018 creator A5035531924 @default.
- W821444018 creator A5037984398 @default.
- W821444018 creator A5065294903 @default.
- W821444018 creator A5084384417 @default.
- W821444018 date "2005-01-01" @default.
- W821444018 modified "2023-10-18" @default.
- W821444018 title "Change of Th1／Th2 Cytokine Equilibrium in Rats with Severe Sepsis and Therapeutic Effect of Recombinant Interleukin-12 and Shenmai Injection （参麦注射液）" @default.
- W821444018 hasPublicationYear "2005" @default.
- W821444018 type Work @default.
- W821444018 sameAs 821444018 @default.
- W821444018 citedByCount "0" @default.
- W821444018 crossrefType "journal-article" @default.
- W821444018 hasAuthorship W821444018A5035531924 @default.
- W821444018 hasAuthorship W821444018A5037984398 @default.
- W821444018 hasAuthorship W821444018A5065294903 @default.
- W821444018 hasAuthorship W821444018A5084384417 @default.
- W821444018 hasConcept C102652120 @default.
- W821444018 hasConcept C126322002 @default.
- W821444018 hasConcept C134018914 @default.
- W821444018 hasConcept C17991360 @default.
- W821444018 hasConcept C187316574 @default.
- W821444018 hasConcept C203014093 @default.
- W821444018 hasConcept C2776178377 @default.
- W821444018 hasConcept C2778384902 @default.
- W821444018 hasConcept C2778690821 @default.
- W821444018 hasConcept C2780159080 @default.
- W821444018 hasConcept C2780199535 @default.
- W821444018 hasConcept C71924100 @default.
- W821444018 hasConcept C74172505 @default.
- W821444018 hasConcept C90924648 @default.
- W821444018 hasConceptScore W821444018C102652120 @default.
- W821444018 hasConceptScore W821444018C126322002 @default.
- W821444018 hasConceptScore W821444018C134018914 @default.
- W821444018 hasConceptScore W821444018C17991360 @default.
- W821444018 hasConceptScore W821444018C187316574 @default.
- W821444018 hasConceptScore W821444018C203014093 @default.
- W821444018 hasConceptScore W821444018C2776178377 @default.
- W821444018 hasConceptScore W821444018C2778384902 @default.
- W821444018 hasConceptScore W821444018C2778690821 @default.
- W821444018 hasConceptScore W821444018C2780159080 @default.
- W821444018 hasConceptScore W821444018C2780199535 @default.
- W821444018 hasConceptScore W821444018C71924100 @default.
- W821444018 hasConceptScore W821444018C74172505 @default.
- W821444018 hasConceptScore W821444018C90924648 @default.
- W821444018 hasIssue "2" @default.
- W821444018 hasLocation W8214440181 @default.
- W821444018 hasOpenAccess W821444018 @default.
- W821444018 hasPrimaryLocation W8214440181 @default.
- W821444018 hasRelatedWork W1964722538 @default.
- W821444018 hasRelatedWork W1984389935 @default.
- W821444018 hasRelatedWork W2035472812 @default.
- W821444018 hasRelatedWork W2075217591 @default.
- W821444018 hasRelatedWork W2159641317 @default.
- W821444018 hasRelatedWork W2349909061 @default.
- W821444018 hasRelatedWork W2350129934 @default.
- W821444018 hasRelatedWork W2355300036 @default.
- W821444018 hasRelatedWork W2357597818 @default.
- W821444018 hasRelatedWork W2376359294 @default.
- W821444018 hasRelatedWork W2377512382 @default.
- W821444018 hasRelatedWork W2382487214 @default.
- W821444018 hasRelatedWork W2389662014 @default.
- W821444018 hasRelatedWork W2394203161 @default.
- W821444018 hasRelatedWork W2405254290 @default.
- W821444018 hasRelatedWork W2431297630 @default.
- W821444018 hasRelatedWork W2982813806 @default.
- W821444018 hasRelatedWork W3024520031 @default.
- W821444018 hasRelatedWork W3025403874 @default.
- W821444018 hasRelatedWork W3141111096 @default.
- W821444018 hasVolume "11" @default.
- W821444018 isParatext "false" @default.
- W821444018 isRetracted "false" @default.
- W821444018 magId "821444018" @default.
- W821444018 workType "article" @default.